BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Leases (Tables)

Leases (Tables)

9 Months Ended

Sep. 30, 2022

Information related to the Company’s right-of-use assets and related liabilities were as follows (in thousands):


	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2022			2021			2022			2021
Cash paid for operating lease liabilities	$	84		$	62		$	219		$	185
Right-of-use assets obtained in exchange for new operating lease obligations	$	—		$	—		$	562		$	48
Weighted-average remaining lease term	2.9 years			3.8 years			2.9 years			3.8 years
Weighted-average discount rate		12.3	%		12.3	%		12.3	%		12.3	%

Schedule of Maturities of Lease Liabilities

Maturities of lease liabilities as of September 30, 2022 for leases that have commenced are as follows (in thousands):


	September 30,
2023	$	831
2024		826
2025		644
2026		144
2027 and thereafter		—
Total future minimum lease obligations		2,445
Less imputed interest		(402	)
Total lease liabilities	$	2,043

Current operating lease liabilities, included in accrued liabilities	$	615
Non current lease liabilities		1,428
Total lease liabilities	$	2,043

Future minimum rental commitments under lease agreements with non-cancelable Operating Leases

Future minimum rental commitments under lease agreements, as of September 30, 2022, with non-cancelable terms greater than one year for each of the years ending December 31 are as follows (in thousands):


	Year Ended
	December 31,
Remainder of 2022	$	205
2023		834
2024		822
2025		584
2026 and thereafter		—
Total future minimum lease obligations		2,445
Less imputed interest		(402	)
Total lease liabilities	$	2,043